PERSPECTA

News from every angle

← Back to headlines

FDA Grants Breakthrough Status to Johnson & Johnson's Cancer Drug for Advanced Head and Neck Cancer

The FDA has granted Breakthrough Therapy Designation to Johnson & Johnson's cancer drug, JNJ-73841937, for the treatment of advanced head and neck cancer.

21 Feb, 16:31 — 21 Feb, 16:31
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

Yahoo2h ago

FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer

Read full article →

Related Stories

Study Links Hidden Gut Virus to Increased Colorectal Cancer Risk

18m ago

Eli Lilly's Taltz-Zepbound Combo Shows Breakthrough in Psoriasis-Obesity Trial

1h ago

Running — the one exercise that midlife women really need to do - The Times

2h ago

Katseye's Manon Takes Temporary Hiatus for Health Reasons

2h ago